Abnormal 5-HT modulation of stress behaviors in the Kv4.2 knockout mouse

Neuroscience

Volumn 170, Issue 4, 2010, Pages 1086-1097

  Lockridge, A ^a   Su, J ^a   Yuan, L L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Antidepressant; Forced swim test; Head movement; Potassium channel; Serotonin; Tail suspension test

Indexed keywords

CITALOPRAM; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; PAROXETINE; POTASSIUM CHANNEL KV4.2; SEROTONIN; SERTRALINE; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; FORCED SWIMMING TEST; HEAD MOVEMENT; IMMOBILIZATION; KNOCKOUT MOUSE; MALE; MOUSE; NEUROMODULATION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; STIMULUS RESPONSE; THERAPY RESISTANCE; WILD TYPE;

ANIMALS; BEHAVIOR, ANIMAL; FLUOXETINE; HEAD; KETANSERIN; MICE; MICE, KNOCKOUT; MOVEMENT; PREFRONTAL CORTEX; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; SHAL POTASSIUM CHANNELS; STRESS, PSYCHOLOGICAL;

EID: 77957103192     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.08.047     Document Type: Article

References (75)

1. Aghajanian G.K., Marek G.J. Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology 1997, 36:589-599.
2. Andrasfalvy B.K., Makara J.K., Johnston D., Magee J.C. Altered synaptic and non-synaptic properties of CA1 pyramidal neurons in Kv4.2 knockout mice. J Physiol 2008, 586:3881-3892.
3. Barnwell L.F., Lugo J.N., Lee W.L., Willis S.E., Gertz S.J., Hrachovy R.A., Anderson A.E. Kv4.2 knockout mice demonstrate increased susceptibility to convulsant stimulation. Epilepsia 2009, 50:1741-1751.
4. Barr A.M., Markou A. Psychostimulant withdrawal as an inducing condition in animal models of depression. Neurosci Biobehav Rev 2005, 29:675-706.
5. Barros H.M., Ferigolo M. Ethopharmacology of imipramine in the forced-swimming test: gender differences. Neurosci Biobehav Rev 1998, 23:279-286.
6. Beique J.C., Campbell B., Perring P., Hamblin M.W., Walker P., Mladenovic L., Andrade R. Serotonergic regulation of membrane potential in developing rat prefrontal cortex: coordinated expression of 5-hydroxytryptamine (5-HT)1A, 5-HT2A, and 5-HT7 receptors. J Neurosci 2004, 24:4807-4817.
7. Bernard C., Anderson A., Becker A., Poolos N.P., Beck H., Johnston D. Acquired dendritic channelopathy in temporal lobe epilepsy. Science 2004, 305:532-535.
8. Binfare R.W., Rosa A.O., Lobato K.R., Santos A.R., Rodrigues A.L. Ascorbic acid administration produces an antidepressant-like effect: evidence for the involvement of monoaminergic neurotransmission. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:530-540.
9. Borsini F., Volterra G., Meli A. Does the behavioral "despair" test measure "despair"?. Physiol Behav 1986, 38:385-386.
10. Carr D.B., Cooper D.C., Ulrich S.L., Spruston N., Surmeier D.J. Serotonin receptor activation inhibits sodium current and dendritic excitability in prefrontal cortex via a protein kinase C-dependent mechanism. J Neurosci 2002, 22:6846-6855.
11. Chen X., Yuan L.L., Zhao C., Birnbaum S.G., Frick A., Jung W.E., Schwarz T.L., Sweatt J.D., Johnston D. Deletion of Kv4.2 gene eliminates dendritic A-type K+ current and enhances induction of long-term potentiation in hippocampal CA1 pyramidal neurons. J Neurosci 2006, 26:12143-12151.
12. Choi J.S., Choi B.H., Ahn H.S., Kim M.J., Han T.H., Rhie D.J., Yoon S.H., Jo Y.H., Kim M.S., Hahn S.J. Fluoxetine inhibits A-type potassium currents in primary cultured rat hippocampal neurons. Brain Res 2004, 1018:201-207.
13. Chourbaji S., Vogt M.A., Fumagalli F., Sohr R., Frasca A., Brandwein C., Hortnagl H., Riva M.A., Sprengel R., Gass P. AMPA receptor subunit 1 (GluR-A) knockout mice model the glutamate hypothesis of depression. FASEB J 2008, 22:3129-3134.
14. Crawley J.N. What's wrong with my mouse?: behavioral phenotyping of transgenic and knockout mice 2000, Wiley-Liss, New York, NY.
15. Cryan J.F., Valentino R.J., Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 2005, 29:547-569.
16. Dekeyne A., Mannoury la Cour C., Gobert A., Brocco M., Lejeune F., Serres F., Sharp T., Daszuta A., Soumier A., Papp M., Rivet J.M., Flik G., Cremers T.I., Muller O., Lavielle G., Millan M.J. S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models. Psychopharmacology (Berl) 2008, 199:549-568.
17. Detke M.J., Rickels M., Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berl) 1995, 121:66-72.
18. Dias Elpo Zomkowski A., Oscar R.A., Lin J., Santos A.R., Calixto J.B., Lucia S., Rodrigues A. Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test. Brain Res 2004, 1023:253-263.
19. Freitas A.E., Budni J., Lobato K.R., Binfare R.W., Machado D.G., Jacinto J., Veronezi P.O., Pizzolatti M.G., Rodrigues A.L. Antidepressant-like action of the ethanolic extract from Tabebuia avellanedae in mice: evidence for the involvement of the monoaminergic system. Prog Neuropsychopharmacol Biol Psychiatry 2009, 34:335-343.
20. Gerson S.C., Baldessarini R.J. Motor effects of serotonin in the central nervous system. Life Sci 1980, 27:1435-1451.
21. Gronli J., Fiske E., Murison R., Bjorvatn B., Sorensen E., Ursin R., Portas C.M. Extracellular levels of serotonin and GABA in the hippocampus after chronic mild stress in rats. A microdialysis study in an animal model of depression. Behav Brain Res 2007, 181:42-51.
22. Guo W., Jung W.E., Marionneau C., Aimond F., Xu H., Yamada K.A., Schwarz T.L., Demolombe S., Nerbonne J.M. Targeted deletion of Kv4.2 eliminates I(to,f) and results in electrical and molecular remodeling, with no evidence of ventricular hypertrophy or myocardial dysfunction. Circ Res 2005, 97:1342-1350.
23. Halberstadt A.L., van der Heijden I., Ruderman M.A., Risbrough V.B., Gingrich J.A., Geyer M.A., Powell S.B. 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice. Neuropsychopharmacology 2009, 34:1958-1967.
24. Hellweg R., Zueger M., Fink K., Hortnagl H., Gass P. Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas. Neurobiol Dis 2007, 25:1-7.
25. Hikosaka O., Sesack S.R., Lecourtier L., Shepard P.D. Habenula: crossroad between the basal ganglia and the limbic system. J Neurosci 2008, 28:11825-11829.
26. Hoffman D.A., Magee J.C., Colbert C.M., Johnston D. K+ channel regulation of signal propagation in dendrites of hippocampal pyramidal neurons. Nature 1997, 387:869-875.
27. Hu H.J., Carrasquillo Y., Karim F., Jung W.E., Nerbonne J.M., Schwarz T.L., Gereau R.W. The kv4.2 potassium channel subunit is required for pain plasticity. Neuron 2006, 50:89-100.
28. Huang C.C., Liang Y.C., Lee C.C., Wu M.Y., Hsu K.S. Repeated cocaine administration decreases 5-HT(2A) receptor-mediated serotonergic enhancement of synaptic activity in rat medial prefrontal cortex. Neuropsychopharmacology 2009, 34:1979-1992.
29. Isbister G.K., Buckley N.A. The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment. Clin Neuropharmacol 2005, 28:205-214.
30. Jung S.C., Kim J., Hoffman D.A. Rapid, bidirectional remodeling of synaptic NMDA receptor subunit composition by A-type K+ channel activity in hippocampal CA1 pyramidal neurons. Neuron 2008, 60:657-671.
31. Kaster M.P., Ferreira P.K., Santos A.R., Rodrigues A.L. Effects of potassium channel inhibitors in the forced swimming test: possible involvement of l-arginine-nitric oxide-soluble guanylate cyclase pathway. Behav Brain Res 2005, 165:204-209.
32. Kim J., Jung S.C., Clemens A.M., Petralia R.S., Hoffman D.A. Regulation of dendritic excitability by activity-dependent trafficking of the A-type K+ channel subunit Kv4.2 in hippocampal neurons. Neuron 2007, 54:933-947.
33. Kulkarni S.K., Dhir A. Effect of various classes of antidepressants in behavioral paradigms of despair. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:1248-1254.
34. Kuo C.C. Imipramine inhibition of transient K+ current: an external open channel blocker preventing fast inactivation. Biophys J 1998, 75:2845-2857.
35. Lambe E.K., Aghajanian G.K. The role of Kv1.2-containing potassium channels in serotonin-induced glutamate release from thalamocortical terminals in rat frontal cortex. J Neurosci 2001, 21:9955-9963.
36. Lambe E.K., Aghajanian G.K. Hypocretin (orexin) induces calcium transients in single spines postsynaptic to identified thalamocortical boutons in prefrontal slice. Neuron 2003, 40:139-150.
37. Lei Z., Deng P., Xu Z.C. Regulation of Kv4.2 channels by glutamate in cultured hippocampal neurons. J Neurochem 2008, 106:182-192.
38. Lino-de-Oliveira C., De Lima T.C., de Padua Carobrez A. Structure of the rat behaviour in the forced swimming test. Behav Brain Res 2005, 158:243-250.
39. Linthorst A.C., Reul J.M. Stress and the brain: solving the puzzle using microdialysis. Pharmacol Biochem Behav 2008, 90:163-173.
40. Liu R.J., Aghajanian G.K. Stress blunts serotonin- and hypocretin-evoked EPSCs in prefrontal cortex: role of corticosterone-mediated apical dendritic atrophy. Proc Natl Acad Sci U S A 2008, 105:359-364.
41. Lucki I., Dalvi A., Mayorga A.J. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology (Berl) 2001, 155:315-322.
42. Mathews T.A., Fedele D.E., Coppelli F.M., Avila A.M., Murphy D.L., Andrews A.M. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. J Neurosci Methods 2004, 140:169-181.
43. Matsushita H., Takeuchi Y., Kosaka K., Fushiki S., Kawata M., Sawada T. Changes in serotonergic neurons in the brain of pyrithiamine-induced acute thiamine-deficient mice. Acta Neuropathol 1999, 98:614-621.
44. Naitoh H., Nomura S., Kunimi Y., Yamaoka K. "Swimming-induced head twitching" in rats in the forced swimming test induced by overcrowding stress: a new marker in the animal model of depression?. Keio J Med 1992, 41:221-224.
45. Nerbonne J.M., Gerber B.R., Norris A., Burkhalter A. Electrical remodelling maintains firing properties in cortical pyramidal neurons lacking KCND2-encoded A-type K+ currents. J Physiol 2008, 586:1565-1579.
46. Nierenberg A.A., Katz J., Fava M. A critical overview of the pharmacologic management of treatment-resistant depression. Psychiatr Clin North Am 2007, 30:13-29.
47. Noda Y., Yamada K., Furukawa H., Nabeshima T. Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia. Br J Pharmacol 1995, 116:2531-2537.
48. Normann C., Clark K. Selective modulation of Ca(2+) influx pathways by 5-HT regulates synaptic long-term plasticity in the hippocampus. Brain Res 2005, 1037:187-193.
49. O'Leary O.F., Bechtholt A.J., Crowley J.J., Valentino R.J., Lucki I. The role of noradrenergic tone in the dorsal raphe nucleus of the mouse in the acute behavioral effects of antidepressant drugs. Eur Neuropsychopharmacol 2007, 17:215-226.
50. Patel J.G., Bartoszyk G.D., Edwards E., Ashby C.R. The highly selective 5-hydroxytryptamine (5-HT)2A receptor antagonist, EMD 281014, significantly increases swimming and decreases immobility in male congenital learned helpless rats in the forced swim test. Synapse 2004, 52:73-75.
51. Pearson K.A., Stephen A., Beck S.G., Valentino R.J. Identifying genes in monoamine nuclei that may determine stress vulnerability and depressive behavior in WistarKyoto rats. Neuropsychopharmacology 2006, 31:2449-2461.
52. Pellow S., Chopin P., File S.E., Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985, 14:149-167.
53. Petit-Demouliere B., Chenu F., Bourin M. Forced swimming test in mice: a review of antidepressant activity. Psychopharmacology (Berl) 2005, 177:245-255.
54. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977, 229:327-336.
55. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
56. Redrobe J.P., Bourin M. Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test. Eur J Pharmacol 1997, 325:129-135.
57. Renard C.E., Dailly E., David D.J., Hascoet M., Bourin M. Monoamine metabolism changes following the mouse forced swimming test but not the tail suspension test. Fundam Clin Pharmacol 2003, 17:449-455.
58. Rocher C., Spedding M., Munoz C., Jay T.M. Acute stress-induced changes in hippocampal/prefrontal circuits in rats: effects of antidepressants. Cereb Cortex 2004, 14:224-229.
59. Serodio P., Rudy B. Differential expression of Kv4 K+ channel subunits mediating subthreshold transient K+ (A-type) currents in rat brain. J Neurophysiol 1998, 79:1081-1091.
60. Shi J., Damjanoska K.J., Singh R.K., Carrasco G.A., Garcia F., Grippo A.J., Landry M., Sullivan N.R., Battaglia G., Muma N.A. Agonist induced-phosphorylation of Galpha11 protein reduces coupling to 5-HT2A receptors. J Pharmacol Exp Ther 2007, 323:248-256.
61. Singh B., Ogiwara I., Kaneda M., Tokonami N., Mazaki E., Baba K., Matsuda K., Inoue Y., Yamakawa K. A Kv4.2 truncation mutation in a patient with temporal lobe epilepsy. Neurobiol Dis 2006, 24:245-253.
62. Slattery D.A., Hudson A.L., Nutt D.J. Invited review: the evolution of antidepressant mechanisms. Fundam Clin Pharmacol 2004, 18:1-21.
63. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 1985, 85:367-370.
64. Stutzmann G.E., Marek G.J., Aghajanian G.K. Adenosine preferentially suppresses serotonin2A receptor-enhanced excitatory postsynaptic currents in layer V neurons of the rat medial prefrontal cortex. Neuroscience 2001, 105:55-69.
65. Svenningsson P., Bateup H., Qi H., Takamiya K., Huganir R.L., Spedding M., Roth B.L., McEwen B.S., Greengard P. Involvement of AMPA receptor phosphorylation in antidepressant actions with special reference to tianeptine. Eur J Neurosci 2007, 26:3509-3517.
66. Thierry B., Steru L., Chermat R., Simon P. Searching-waiting strategy: a candidate for an evolutionary model of depression?. Behav Neural Biol 1984, 41:180-189.
67. van der Stelt H.M., Breuer M.E., Olivier B., Westenberg H.G. Permanent deficits in serotonergic functioning of olfactory bulbectomized rats: an in vivo microdialysis study. Biol Psychiatry 2005, 57:1061-1067.
68. Wang L., Yuan L.L. Activation of muscarinic acetylcholine receptors leads to long-term depression of the hippocampal-mPFC pathway. J Physiol 2009, 587:5139-5147.
69. Wang R., Xu Y., Wu H.L., Li Y.B., Li Y.H., Guo J.B., Li X.J. The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors. Eur J Pharmacol 2008, 578:43-50.
70. Weisstaub N.V., Zhou M., Lira A., Lambe E., Gonzalez-Maeso J., Hornung J.P., Sibille E., Underwood M., Itohara S., Dauer W.T., Ansorge M.S., Morelli E., Mann J.J., Toth M., Aghajanian G., Sealfon S.C., Hen R., Gingrich J.A. Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 2006, 313:536-540.
71. Willins D.L., Meltzer H.Y. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. J Pharmacol Exp Ther 1997, 282:699-706.
72. Yeung S.Y., Millar J.A., Mathie A. Inhibition of neuronal KV potassium currents by the antidepressant drug, fluoxetine. Br J Pharmacol 1999, 128:1609-1615.
73. Yuen E.Y., Jiang Q., Chen P., Feng J., Yan Z. Activation of 5-HT2A/C receptors counteracts 5-HT1A regulation of N-methyl-d-aspartate receptor channels in pyramidal neurons of prefrontal cortex. J Biol Chem 2008, 283:17194-17204.
74. Zhao C., Wang L., Netoff T., Yuan L.-L. Dendritic mechanisms controlling the threshold and timing requirement of synaptic plasticity. Hippocampus 2010, n/a. 10.1002/hipo.20748.
75. Zhou F.M., Hablitz J.J. Activation of serotonin receptors modulates synaptic transmission in rat cerebral cortex. J Neurophysiol 1999, 82:2989-2999.